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Summary A screening programme for early gastric cancer was introduced in the state of Tachira, Venezuela,
in 1980. Screening was performed by photofluorography, using two mobile units. The efficacy of this
programme in reducing mortality from stomach cancer was evaluated by means of a case-control study. Cases
were 241 individuals who died from stomach cancer in the period 1985-89. Ten live controls per case were
drawn from the electoral rolls, matched by sex, age and residence. Exposure to the screening examination of
cases and controls was assessed through individual linkage with the programme's centralised database. After
the exclusion of examinations occurring within the 6 months preceding the case's diagnosis, the odds ratio
(OR) of dying from stomach cancer for those screened was 1.26 (CI 0.83-1.91) and the OR in females was
lower than in males: 0.77 (CI 0.33-1.78) and 1.52 (CI 0.94-2.47) respectively. Odds ratios associated with
years since last test and number of tests did not differ significantly from 1. These results show the inefficacy of
the programme in reducing mortality from gastric cancer in the area. In an attempt to determine whether this
result was due to selection bias, an analysis restricted to subjects who had been screened at least once was
performed. When examinations occurring after an index date at various intervals before the case's diagnosis
were excluded, the screening test appeared to protect from death, although confidence intervals of the odds
ratios are large, for example OR = 0.47 (CI 0.24-0.98) when excluding tests within 1 month.
Stomach cancer, despite a decline in incidence almost
everywhere, remains the second most common cancer world-
wide, after lung cancer (Parkin et al., 1993). In Japan, where
stomach cancer is a major public health problem, there has
been an extensive attempt to reduce mortality by early detec-
tion and treatment. The population screening programme
aims to examine 30% of the population aged 40 or over each
year by photofluorography (Oshima, 1988). The test aims at
detecting the disease at an early stage, when cancer is
confined to the gastric mucosa and submucosa. The Japanese
programmes were introduced as a community service, with-
out any formal randomised trial, so that evaluation of their
success has depended upon analyses of time trends in
incidence and mortality, comparisons of gastric cancer mor-
tality in screened versus unscreened populations and case-
control analyses (see reviews by Oshima, 1988; Hisamichi,
1989; Hisamichi et al., 1991). The problem ofinterpreting the
results of non-randomised evaluations has meant that there is
still some scepticism concerning the applicability of mass
screening for gastric cancer elsewhere (Chamberlain et al.,
1986; Miller et al., 1990).
In common with other mountainous parts of South and
Central America, the state of Tachira in the western part of
Venezuela has high rates of gastric cancer - age-standardised
mortality rates in 1982-84 were 49.6 per 105 in men and 34.1
in women, compared with 40.8 and 19.0 in men and women,
respectively, in Japan in 1987-88 (Aoki et al., 1992). A
screening programme was started in 1980, by means of the
established Japanese methodology of six film indirect
photofluorography using double contrast. The objective was
to examine as large a proportion of the population aged 35
or over as possible at intervals of 1-2 years with the aim of
reducing mortality from gastric cancer. Two mobile screening
units were used, moving to different localities; they were
installed in a locality and subjects were invited for screening
by rural nurses, using population lists for health centres close
to the screening unit's location.
In the years 1981-89 some 114,000 examinations were
performed, resulting in the detection of 445 cancers. In this
paper, we evaluate the success of the programme in preven-
ting death from gastric cancer, using a case-control
analysis.
Materials and methods
A total of 250 individuals who were resident in Tachira State
and who died from gastric cancer during the period 1985-89
formed the case group. These represented almost all of the
deaths from gastric cancer in this period for which the death
certificate diagnosis could be confirmed by tracing the
relevant clinical records in hospitals or medical centres. The
date of diagnosis, as noted in the clinical record, was
abstracted for each case, together with information on the
basis of diagnosis and the presence or absence of clinical
metastases. Seventy-four per cent of the cases had been histo-
logically confirmed, 8.3% had a clinical diagnosis only, and
the remainder were diagnosed by radiology, cytology or
other means.
Ten live controls were matched to each case; they were
drawn from the electoral registers of the case's polling district
for the year of death of the case, matching on sex and age
(± 3 years). Polling districts are defined as the place where
one votes, and as they cover small areas the sampling proce-
dure entailed matching by neighbourhood. Electoral rolls
include all residents aged 18 +. Nine cases were excluded
because of an error in selecting the controls (controls of the
wrong sex were included), leaving 241 match sets (241 cases
and 2410 controls) for the analysis.
For each case and control subject, the centralised database
of the screening programme was searched; if found, their
complete screening history (date and results of radiological,
endoscopic and biopsy examinations) was abstracted.
Exposure definition
In the screening database 105 cases and 376 controls could
be traced, corresponding to a crude prevalence of 43% of
case subjects and 16% of controls ever having been
screened.
For 40 of the cases there was a malignant diagnosis at a
screening examination which took place before the date of
diagnosis in the clinical record, and the date ofdiagnosis was
advanced to the date of the first biopsy which resulted in
malignancy.
Four index dates were used in the definition of exposure to
the screening programme:
A. the date of diagnosis of the case (including the test, if
any, which resulted in the diagnosis of gastric cancer);
B. 1 month before the date of diagnosis of the case;
C. 6 months before the date of diagnosis of the case;
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D. 1 year before the date of diagnosis of the case.
Any examination which was performed after the index date
was excluded, irrespective of the case control status.
Odds ratios (ORs) of dying from gastric cancer, given
exposure to the screening programme, were estimated
through conditional logistic regression for matched data
(Breslow & Day, 1980); consequently, ORs were adjusted by
sex, age and neighbourhood. ORs greater than 1 indicate a
higher risk of dying from gastric cancer if screened, and ORs
lower than 1 indicate a lower risk.
Results
Table I shows the distribution of cases and controls by
screening history (ever/never). The crude prevalence of con-
trols ever examined is 11.0% with no exclusion of tests up to
diagnosis of the case. It is obvious that, among the cases, an
excess number of examinations took place close to their date
of diagnosis; passing from definition A to B the prevalence of
exposed cases decreases dramatically from 35.3% to 19.9%,
while the corresponding figure for controls, 11.0%, does not
change.
The ORs associated with the four exposure definitions to
the screening programme are also shown in Table I. A
significant OR of 4.82 (CI 3.54-6.57) is observed for
screened subjects versus those not screened when all tests are
considered (exposure defined as in A). Most of this excess
risk is confined to examinations close to the diagnosis: the
OR decreases to 2.08 (CI 1.96-2.96) when excluding tests
within 1 month before diagnosis (exposure B), and to 1.26
(CI 0.83-1.91) when excluding tests within 6 months
(exposure C); the OR does not change further when ex-
cluding examinations within 1 year before diagnosis:
OR= 1.32 (CI 0.86-2.03) (exposure D).
The risk associated with screening is analysed in greater
detail in Table 11 for exposure as defined in C. Most of the
excess risk is confined to men: their OR is 1.52 (CI
0.94-2.47), while the risk among women is 0.77 (CI
0.33-1.78); ORs are higher for men than for women
whatever the exposure definition adopted (data not
shown).
No excess risk was detected for examination within 3 years
before diagnosis, while a significant OR of 1.81 (CI
1.02-3.21) was observed for examinations occurring 3 years
or more before; this excess risk is confined to males: the OR
is 2.18 (CI 1..11-4.27).
The results presented so far clearly show that those who
attended the screening programme are at a higher risk of
dying from gastric cancer than the general population; quite
possibly many attend for screening because of the presence
of symptoms. In order to avoid this selection bias, an
analysis limited to those subjects who had had at least one
screening test was performed. Any screening test, irrespective
ofwhen it was performed, would define the subject as eligible
for this analysis. The only tests excluded in defining the study
population were those occurring among cases after the date
of diagnosis. Exposure was then defined as above, thus ex-
cluding examinations performed after the index date. Table
Table I Distribution of cases and controls by exposure to screening and odds ratio (OR) estimates,
screened vs not screened, 95% confidence limits. Total number of cases and controls is 241 and 2410
respectively
Screened Not
Index date No. % screened OR CI
A At diagnosis
Cases 85 35.3 156 4.82 (3.54-6.57)
Controls 265 11.0 2145
B One month before diagnosis
Cases 48 19.9 193 2.08 (1.96-2.96)
Controls 265 11.0 2145
C Six months before diagnosis
Cases 30 12.4 211 1.26 (0.83-1.91)
Controls 248 10.3 2162
D Twelve months before diagnosis
Cases 28 11.6 213 1.32 (0.86-2.03)
Controls 222 9.2 2188
Table II Odds ratios (ORs) and confidence intervals (CIs) associated with
exposure to screening tests, time since last test and number of tests. Exposure
defined as in C - tests within 6 months excluded. Total number of cases and
controls entering the analysis is 241 and 2410 respectively
No. of OR (CI)
Exposure C cases All subjects Males Females
Not screeneda 211 1 1 1
Screened 30 1.26 1.52 0.77
(0.83-1.91) (0.94-2.47) (0.33-1.78)
Years since last test
Nevera 211 1 1 1
<3 14 0.94 1.16 0.54
(0.53-1.67) (0.60-2.23) (0.16-1.81)
3 + 16 1.81 2.18 1.15
(1.02-3.21) (1.11-4.27) (0.37-3.53)
Number of tests
oa 211 1 1 1
1 27 1.27 1.55 0.76
(0.82-1.97) (0.94-2.55) (0.31-1.88)
2 + 3 1.12 1.33 0.79
(0.33-3.75) (0.30-5.93) (0.10-6.37)
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III presents the results of this analysis, in which the index
date is 1 month before the diagnosis of the case (definition
B). The overall risk for subjects screened before the index
date is 0.47 (CI 0.24-0.98) relative to those not screened, and
is statistically significant. The protective effect of the test
appears to be constant by time since last examination, but
confidence intervals are large because of the relatively small
numbers involved - the number of discordant sets contri-
buting to this analysis is 64.
The same analysis was repeated with the third exposure
definition (C), the results of which are presented in Table IV.
The exclusion of recent examinations does not yield higher
estimates of the screening efficacy: the OR for those classified
as screened versus those not screened is 0.25 (CI 0.12-0.51);
the beneficial effect is statistically significant whether the last
test occurred within the last 3 years or earlier.
Discussion
This study was designed to get a first insight into the impact
of the screening programme for gastric cancer in Tachira
State, Venezuela, which has been going on for over 10 years.
The programme is expensive and the evaluation of its
effectiveness was of high priority. Moreover, other countries
in the same areas are currently considering the introduction
of similar progammes; consequently, it is important to know
the results of the only experience conducted under similar
conditions. Our study shows that the programme in Tachira
State has failed to reduce mortality from gastric cancer
because of the low coverage of the population.
The main defect of case-control studies in the evaluation
of the efficacy of screening is the effect of selection bias.
Cases and controls are drawn from a population with access
to screening, and the evaluation estimates the risk of disease
in those who attend for screening versus those who do not.
The fact that risk of the disease outcome under study (here,
death from cancer) differs in the two groups irrespective of
screening is a potent source of bias (Connor et al., 1991;
Table III Cases and controls who had at least one screening test.
Exposure defined as in B - tests within 1 month excluded
All subjects
Cases Controls OR CI
Not screened' 37 111 1
Screened 48 264 0.47 (0.24-0.98)
Total 85 375
Years since last test
Never' 37 111 1
<3 34 173 0.48 (0.24-0.97)
3 + 14 91 0.45 (0.19-1.10)
Total 85 375
aTests occurred after the index date; reference category.
Table IV Cases and controls who had at least one screening test,
irrespective of the index date. Exposure defined as in C - tests within
6 months excluded
All subjects
Cases Controls OR CI
Not screeneda 55 129 1
Screened 30 246 0.25 (0.12-0.51)
Total 85 375
Years since last test
Never' 55 129 1
<3 14 151 0.15 (0.06-0.39)
3 + 16 95 0.40 (0.17-0.95)
Total 85 375
'Tests occurred after the index date; reference category.
Moss, 1991; Weiss et al., 1992). Selection bias is a problem in
the present study, since there is a high risk of death in those
accepting screening, presumably because they are using the
screening programme as a diagnostic service for symptoms of
gastric cancer. Such a finding might have been anticipated
from the low prevalence of screening (some 12.4% of those
in the age groups at risk ofdeath from gastric cancer). In the
years 1981-89, only some 16% of the cancers detected by
screening were defined as 'early'.
Experience in western countries suggests that persons of
higher social class are more likely to make use of preventive
services such as screening; if this were so for the gastric
cancer screening programme in Venezuela, we might expect
this selection bias to produce an apparent protective effect of
screening, since gastric cancer is less common in the higher
social classes. On the other hand in many developing coun-
tries, a large part of the population has limited access to
health facilities, especially if resident in rural areas (because
health centres are concentrated in cities and public transport
is almost non-existent and because health care is not free);
thus the screening units when installed in villages are the only
chance of having a diagnostic examination for those affected
by gastric symptoms of a variety of disorders, including
cancer. In western countries self-selection for screening does
not operate in a predictable direction. In the Health
Insurance Plan of the Greater New York Breast Cancer
Screening Trial (HIP Trial), among women allocated to the
screening arm those who accepted the examination were at
higher risk of breast cancer than those who refused it (Fried-
man & Dubin, 1991). In a case-control study of mortality
from breast cancer, Palli et al. (1986) found that women
referring themselves to an early diagnosis clinic were at twice
the risk of dying from breast cancer in comparison with
those who did not. On the contrary, in the UK trial of early
detection of breast cancer, women who accepted screening
were at lower risk of dying from breast cancer than those
who did not (Moss, 1991).
The over-representation of high-risk people among the
screened in our study could theoretically be corrected by
matching cases and controls for the presence of symptoms of
the disease at the time of diagnosis. Information on the
presence of symptoms in screen-detected cases at the time of
diagnosis was not available through the programme and
obviously could not be traced retrospectively. However, it
should be emphasised that control ofselection bias by adjust-
ing for symptoms is likely to be only a theoretical option, as
symptoms of gastric cancer are non-specific and common to
other gastric disorders such as chronic atrophic gastritis and
intestinal metaplasia, the prevalence of which is very high
(45%) in populations of South America showing high
incidence rates of gastric cancer (Correa et al., 1990).
Consequently, selection bias was controlled for through
matching by age and residence (which allows similar pro-
bability of having access to the examination for cases and
controls), through the exposure definition, and finally by
limiting the analysis to those who had been screened at least
once.
Interestingly, in an investigation which simulated the
results of case-control studies to evaluate the efficacy of
screening for breast cancer, and which took advantage of the
results of the HIP Trial, it was shown that control by a
variety of confounders, including an indicator of symptoms,
did eliminate the effect of selection bias in the 'population-
based' study design; on the other hand it did not materially
affect the estimates of the ORs when the study was limited to
screened women (Friedman & Dubin, 1991).
The present analysis does provide some suggestion of
benefit from screening in the observation that, when tests
within 6 months of diagnosis are excluded, the risk of death
in the 3 years following a negative test is about half that
when the last test was more than 3 years earlier.
In a similar case-control study in the town of Nose, Japan,
Oshima et al. (1986) found an OR for screened versus un-
screened subjects of 0.52 in men and 0.49 in women when
tests within 1 year ofdiagnosis were excluded. Tests within 2CASE-CONTROL STUDY OF GASTRIC CANCER 1105
years of diagnosis (excluding the diagnostic test) were
associated with a very low OR (0.17) compared with earlier
tests (0.65). The difference from the results in Tachira are
presumably related to the greater intensity of screening -
some 67% of the controls from the Nose population had had
one or more tests, and 23/56 (41%) of cases detected by
screening were early gastric cancer. Nevertheless, there was
some evidence of attendance related to symptoms - ORs (in
men only) were higher when tests within a year of diagnosis
were included.
One other case-control study has been performed in Japan
(Fukao et al., 1987), comparing screening histories before
diagnosis in 367 cases of advanced stomach cancer with
controls matched for sex, age and residence (precinct). A
protective effect was observed up to 3 years since the last
negative test; this was significant (OR = 0.34, 95% CI
0.25-0.48) in the first year after screening. The prevalence of
screening was high in this population - 77% of controls had
been screened at some time, 60% in the previous year.
The questions that remain concerning the efficacy of gast-
ric cancer screening cannot be resolved by further observa-
tional studies, which do not address the effects of selection
bias (positive or negative) on the outcome. Adoption of
gastric cancer screening as public health policy in Japan
means that the opportunity for a randomised trial, with a
non-screened control group, is no longer feasible. One ran-
domised trial is in progress (Hisamichi et al., 1991), in which
39 municipalities were randomised in two groups. People
resident in municipalities belonging to the first group and
aged 50, and people from the second group of residence aged
60, form the intervention group. They were sent a personal
invitation to attend for screening while the rest of the
population was offered the examination in the usual way.
Although there was some difference in screening attendance
between the intervention group and the rest of the popula-
tion in the year following the intervention, this had declined
to a very small differential by the second year, and it is
inconceivable that a demonstrable difference in mortality will
result. Outside Japan, we are aware only of mass screening
by radiography in Tachira State, Venezuela, and on a smaller
scale in Ecuador. These programmes are, at present, small
and with insufficiently high population coverage, so that even
a randomised controlled trial would have insufficient power
to demonstrate the likely degree of efficacy. Only a substan-
tial improvement of the population coverage would permit a
proper evaluation.
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